Twitter | Search | |
Ana Vallejo
Periodista especializada en salud. Responsable de comunicación en . Perfil personal
889
Tweets
905
Following
975
Followers
Tweets
Ana Vallejo retweeted
Myeloma Patients Europe Jun 19
With the aim of providing an overview of personalised medicines in , MPE will hold a webinar on Thursday 25 June (18:00-19:00 CET). It will be given by Dr Annemiek Broijl (Erasmus MC Cancer Institute, Rotterdam, Netherlands). Register now!
Reply Retweet Like
Ana Vallejo retweeted
Pacientes LMC Jun 18
After , here we have a list of posters and abstracts related to from the clinical point of view, so that all those who may be interested can access them. and : thank you for letting us be part of
Reply Retweet Like
Ana Vallejo retweeted
Myeloma Patients Europe Jun 17
ended yesterday. It was the largest congress in its history with 12.614 attendees. Big thanks to all doctors, advocates and stakeholders who visit our booth, meet us and help us to keep growing. A summary of the key updates in will be available soon!
Reply Retweet Like
Ana Vallejo retweeted
Myeloma Patients Europe Jun 15
Iberdomide+dex showed a favorable safety and activity profile in patients with heavily pretreated
Reply Retweet Like
Ana Vallejo retweeted
Myeloma Patients Europe Jun 15
Oportunities and challenges of personalised medicine
Reply Retweet Like
Ana Vallejo retweeted
Myeloma Patients Europe Jun 15
Apparently current quality of life tools do not appropiately capture QoL in CAR-T
Reply Retweet Like
Ana Vallejo retweeted
Myeloma Patients Europe Jun 15
There are huge expectations on . Integrating patient preferences is essential
Reply Retweet Like
Ana Vallejo Jun 15
Great talk of about cell treatment and the example of the in which is involved
Reply Retweet Like
Ana Vallejo Jun 15
What do we know about toxicities in CAR-T cell treatment?
Reply Retweet Like
Ana Vallejo retweeted
Myeloma Patients Europe Jun 15
Room full of attendees to listen to the talk about CAR-T cell therapy in which Prof and our CEO will give a talk
Reply Retweet Like
Ana Vallejo Jun 14
Muchas gracias!
Reply Retweet Like
Ana Vallejo retweeted
Pacientes LMC Jun 14
Muchas felicidades a , compañera de , por su primera publicación en póster en
Reply Retweet Like
Ana Vallejo retweeted
Pacientes LMC Jun 14
Help us by playing a quiz at Incyte. We've already got over 10.000€!!! Right TKI. Right Time.
Reply Retweet Like
Ana Vallejo retweeted
Myeloma Patients Europe Jun 14
Happy to be in the list of influencers of ! Well done !!
Reply Retweet Like
Ana Vallejo retweeted
CML AdvocatesNetwork Jun 14
Why did test the ESMO-MCBS (Magnitude of Clinical Benefit Scale)? Support oncologists & in decision making.
Reply Retweet Like
Ana Vallejo retweeted
Neus Fabregat Jun 14
Yesterday we show how you can submit your Research Project within during
Reply Retweet Like
Ana Vallejo retweeted
Myeloma Patients Europe Jun 14
We are one of the authors "Does quality of life in multiple myeloma patients differ between nationalities? A European multinational study” that will be presented this evening. Annemieke Van Dongen-Leunis explains us the main results in an interview
Reply Retweet Like
Ana Vallejo Jun 14
Una vez más, gran nivel de la hematología española en , especialmente en liderando investigaciones destacadas
Reply Retweet Like
Ana Vallejo retweeted
Myeloma Patients Europe Jun 14
The 24th Congress of the started yesterday in Amsterdam with the biggest attendance in its history. More than 12.000 attendees got together to discuss the latest updates in . Find here the photo gallery!
Reply Retweet Like
Ana Vallejo retweeted
EHA Jun 13
Happening now at : Press briefing Day 1 where we highlight newsworthy research
Reply Retweet Like